AI is set to be used in NHS hospitals for the first time after health regulator gives the green light for its deployment in radiology departments

Original Articles:

  1. https://www.bioworld.com/articles/699868-ai-approved-for-use-in-the-uk-health-system-for-the-first-time?v=preview
  2. https://www.dailymail.co.uk/health/article-12395513/AI-used-NHS-hospitals-health-regulator-green-light-radiology-departments.html
Artificial Intelligence in UK hospitals!

Artificial intelligence is now being used by the UK’s National Health Service (NHS) Hospitals to help to assess images obtained from x-rays and scans thereby reducing the reporting time by  up … [Read More]

Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society

Original Articles:

  1. https://journals.sagepub.com/doi/10.1177/19322968231190408 
  2. https://journals.sagepub.com/doi/abs/10.1177/19322968231187661 
  3. https://journals.sagepub.com/doi/abs/10.1177/19322968231186626
What is lipohypertrophy?

Lipohypertrophy (LH) is the increased amount of fatty tissue underneath the skin caused by injecting or infusing insulin over time. It is very common but frequently not recognized by a … [Read More]

Prescribing Produce could reduce the risk of developing Type 2 Diabetes

Original Article: https://www.sciencedirect.com/science/article/pii/S2405844023056487#abs0010

You are what you eat

A healthy diet is important to overall health, but especially important to manage risk of developing type 2 diabetes (T2D). Not meeting the minimum daily requirement of fruits and vegetables is a … [Read More]

Diabetes technologies work, but does everyone have a fair chance?

Original Article: https://journals.sagepub.com/doi/10.1177/19322968231183985

Continuous glucose monitors (CGMs) are now commonly used by adults and children with type 1 diabetes and recently by people with type 2 diabetes who take insulin. The benefits from CGMs are well-established including improved glucose levels, … [Read More]

The Need for New Therapies for Type 1 Diabetes

Original Article: https://www.medicalnewstoday.com/articles/fda-approves-first-cellular-therapy-for-type-1-diabetes-what-does-it-do

In 2021, about 8.4 million people globally were living with type 1 diabetes (T1D). There is currently no cure and those with T1D must use insulin for their entire life. For some individuals their life can be … [Read More]